Blog
RSS FeedPosted by Michael Wonder on 18 Sep 2020
EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation
18 September 2020 - EMA’s CHMP has completed its review of results from the RECOVERY study arm that involved the ...
Posted by Michael Wonder on 18 Sep 2020
Decision to fund an additional brand of budesonide with eformoterol
18 September 2020 - PHARMAC is pleased to announce a decision to fund an additional brand of budesonide with eformoterol ...
Posted by Michael Wonder on 18 Sep 2020
Chi-Med announces second NDA acceptance in China for surufatinib in pancreatic neuroendocrine tumours
17 September 2020 - Hutchison China MediTech today announces that its new drug application for surufatinib for the treatment of ...
Posted by Michael Wonder on 18 Sep 2020
Proposal to fund emicizumab for people with haemophilia A
18 September 2020 - PHARMAC is seeking feedback on a proposal to fund emicizumab (Hemlibra), a new treatment for people with ...
Posted by Michael Wonder on 17 Sep 2020
11 state treasurers call on Gilead to reduce remdesivir pricing
18 September 2020 - The medicine has shown promise as a treatment for novel coronavirus. ...
Posted by Michael Wonder on 17 Sep 2020
Transparency Commission publishes its opinion on Veklury
17 September 2020 - Gilead withdrew its request for the reimbursement of remdesivir in France on 31 August 2020. ...
Posted by Michael Wonder on 17 Sep 2020
ChemoCentryx announces FDA acceptance of the avacopan new drug application for the treatment of ANCA associated vasculitis
17 September 2020 - FDA sets PDUFA goal date of 7 July 2021. ...
Posted by Michael Wonder on 17 Sep 2020
Real world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward
15 September 2020 - There is growing interest globally in using real world data and real-world evidence for health technology assessment. ...
Posted by Michael Wonder on 17 Sep 2020
Trump’s ‘most favored nation’ executive order on drug prices is a scam for seniors
16 September 2020 - The White House announced a most favoured nations executive order on Sunday, its latest attempt to ...
Posted by Michael Wonder on 17 Sep 2020
NICE announces autumn series of virtual events
17 September 2020 - Three webinar style events will feature a number of high-profile speakers. ...
Posted by Michael Wonder on 17 Sep 2020
Eton Pharmaceuticals provides update on the FDA review of EM-100
16 September 2020 - Eton Pharmaceuticals reported that its partner has not yet received a communication from the U.S. FDA regarding ...
Posted by Michael Wonder on 17 Sep 2020
'Burning liquid fire': sick Aussies endure agonising injections while painless drug is available overseas
17 September 2020 - Every fortnight, 10-year-old Ciera Ayer is forced to endure hours of agony when she is injected ...
Posted by Michael Wonder on 17 Sep 2020
Rare Disorders New Zealand supports Human Rights Commission case against PHARMAC
17 September 2020 - Rare Disorders New Zealand supports patient advocate Fiona Tolich’s Human Rights Commission case against PHARMAC for ...
Posted by Michael Wonder on 17 Sep 2020
Government throwing billions at COVID-19 but not doubling PHARMAC budget 'makes no sense' - Malcolm Mullholland
17 September 2020 - The PHARMAC model is broken, according to an advocate for increased access to life-saving drugs in ...
Posted by Michael Wonder on 16 Sep 2020
If money is no longer an issue, I have one request - double the PHARMAC budget
16 September 2020 - Long live the year 2020 - said no one ever. ...